Needham & Company Reiterates Buy on Progenics Pharma (PGNX); Anticipates Oral Relistor Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. HNGE
9. INSP
10. SPY

Go back to Needham & Company Reiterates Buy on Progenics Pharma (PGNX); Anticipates Oral Relistor Approval

Progenics Pharma (PGNX) Tops Q4 EPS by 4c

March 11, 2016 8:02 AM EST

Progenics Pharma (NASDAQ: PGNX) reported Q4 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $2.25 million.

For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.

... More

Trading Radar for 3/11: Genesco (GCO), Hibbett Sports (HIBB), The Buckle (BKE), Lifetime Brands (LCUT) Report

March 10, 2016 2:27 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EST

Export Prices: ex. Ag - no Street consensusImport Prices: ex. Oil - no Street consensus

Earnings:

Century Casinos (Nasdaq:... More